Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Renal Denervation Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Ultrasound Ablation, Radiofrequency Ablation, Pharmacologic Ablation, Microinfusion)
5.2.2. By Product (Catheters, Single Electrode Catheter, Multi Electrode Catheter, RF Generator, Others)
5.2.3. By Therapeutic Area (Hypertension, Heart Failure, Diabetes, Renal Failure, Others)
5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Technology
5.3.2. By Product
5.3.3. By Therapeutic Area
5.3.4. By End User
5.3.5. By Region
6. North America Renal Denervation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Product
6.2.3. By Therapeutic Area
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Renal Denervation Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Technology
6.3.1.2.2. By Product
6.3.1.2.3. By Therapeutic Area
6.3.1.2.4. By End User
6.3.2. Mexico Renal Denervation Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Technology
6.3.2.2.2. By Product
6.3.2.2.3. By Therapeutic Area
6.3.2.2.4. By End User
6.3.3. Canada Renal Denervation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Technology
6.3.3.2.2. By Product
6.3.3.2.3. By Therapeutic Area
6.3.3.2.4. By End User
7. Europe Renal Denervation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Product
7.2.3. By Therapeutic Area
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Renal Denervation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Product
7.3.1.2.3. By Therapeutic Area
7.3.1.2.4. By End User
7.3.2. Germany Renal Denervation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Product
7.3.2.2.3. By Therapeutic Area
7.3.2.2.4. By End User
7.3.3. United Kingdom Renal Denervation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Product
7.3.3.2.3. By Therapeutic Area
7.3.3.2.4. By End User
7.3.4. Italy Renal Denervation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Technology
7.3.4.2.2. By Product
7.3.4.2.3. By Therapeutic Area
7.3.4.2.4. By End User
7.3.5. Spain Renal Denervation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Technology
7.3.5.2.2. By Product
7.3.5.2.3. By Therapeutic Area
7.3.5.2.4. By End User
8. Asia-Pacific Renal Denervation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Product
8.2.3. By Therapeutic Area
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Renal Denervation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Product
8.3.1.2.3. By Therapeutic Area
8.3.1.2.4. By End User
8.3.2. India Renal Denervation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Product
8.3.2.2.3. By Therapeutic Area
8.3.2.2.4. By End User
8.3.3. Japan Renal Denervation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Product
8.3.3.2.3. By Therapeutic Area
8.3.3.2.4. By End User
8.3.4. South Korea Renal Denervation Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Product
8.3.4.2.3. By Therapeutic Area
8.3.4.2.4. By End User
8.3.5. Australia Renal Denervation Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Product
8.3.5.2.3. By Therapeutic Area
8.3.5.2.4. By End User
9. South America Renal Denervation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Product
9.2.3. By Therapeutic Area
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Renal Denervation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Product
9.3.1.2.3. By Therapeutic Area
9.3.1.2.4. By End User
9.3.2. Argentina Renal Denervation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Product
9.3.2.2.3. By Therapeutic Area
9.3.2.2.4. By End User
9.3.3. Colombia Renal Denervation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Product
9.3.3.2.3. By Therapeutic Area
9.3.3.2.4. By End User
10. Middle East and Africa Renal Denervation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Product
10.2.3. By Therapeutic Area
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Renal Denervation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Product
10.3.1.2.3. By Therapeutic Area
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Renal Denervation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Product
10.3.2.2.3. By Therapeutic Area
10.3.2.2.4. By End User
10.3.3. UAE Renal Denervation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Product
10.3.3.2.3. By Therapeutic Area
10.3.3.2.4. By End User
10.3.4. Egypt Renal Denervation Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Technology
10.3.4.2.2. By Product
10.3.4.2.3. By Therapeutic Area
10.3.4.2.4. By End User
10.3.5. Turkey Renal Denervation Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Technology
10.3.5.2.2. By Product
10.3.5.2.3. By Therapeutic Area
10.3.5.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As reported)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. Medtronic Plc.
13.6.2. Boston Scientific Corporation
13.6.3. Abbott Laboratories, Inc.
13.6.4. Terumo Corporation
13.6.5. Johnson & Johnson
13.6.6. Cordis Corporation
13.6.7. ReCor Medical, Inc. (Otsuka Holdings)
13.6.8. Cardiosonic Ltd
13.6.9. Mercator MedSystems, Inc
13.6.10. Renal Dynamics Limited
14. Strategic Recommendations